Dec 11, 2023 FDA Reports of Secondary Malignancies Following Chimeric Antigen Receptor (CAR) T Cell Therapies and Relative Risk: an EBMT-EHA-GoCART Coalition Statement
Nov 27, 2023 Report from the Lymphoma Working Party Educational Course - 15-17 November 2023 - Warsaw, Poland